- Home
- /
- Drugs
- /
- C
- /
- Cisatracurium besylate
- /
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Zydus Lifesciences Limited
Cisatracurium besylate
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Zydus Lifesciences Limited
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Piramal Healthcare UK Limited
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Hikma Pharmaceuticals USA Inc.
- Nimbex CISATRACURIUM BESYLATE 2 mg/mL AbbVie Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Zydus Pharmaceuticals USA Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Zydus Lifesciences Limited
- Nimbex CISATRACURIUM BESYLATE 2 mg/mL AbbVie Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Zydus Pharmaceuticals USA Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Sandoz Inc
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Hikma Pharmaceuticals USA Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Caplin Steriles Limited
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Somerset Therapeutics, LLC
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Piramal Healthcare UK Limited
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Civica, Inc.
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Caplin Steriles Limited
- Cisatracurium besylate CISATRACURIUM BESYLATE 2 mg/mL Sandoz Inc
- Cisatracurium Besylate CISATRACURIUM BESYLATE 2 mg/mL Somerset Therapeutics, LLC
Summary of product characteristics
Effective Time
20221017
Version
2
Spl Product Data Elements
cisatracurium besylate cisatracurium besylate CISATRACURIUM BESYLATE CISATRACURIUM BENZENESULFONIC ACID BENZYL ALCOHOL WATER
Application Number
ANDA213527
Brand Name
Cisatracurium besylate
Generic Name
cisatracurium besylate
Product Ndc
72785-0011
Product Type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Container Label (20 mg/10 mL) NDC 72758-0011-1 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 mL Multiple-Dose Vial Rx only Carton Label (20 mg/10 mL) NDC 72758-0011-1 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 mL Multiple-Dose Vial Rx only Carton Label (20 mg/10 mL) NDC 72758-0011-6 Cisatracurium Besylate Injection, USP 20 mg/10 mL* (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Injection 0.9% benzyl alcohol (added as a preservative) 10 x 10 mL Multiple-Dose Vial Rx only vial label carton for 1 vial carton of 10 vials
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.